Report

April 13

Broughton Nicotine Services are delighted to sponsor and present at ENDS Europe 2021.

Broughton Nicotine Services Chief Regulatory Officer, Dr Nveed Chaudhary to present on the future challenges of the ENDS regulatory battleground and the importance of total harm reduction.

ENDS is Europe’s leading Electronic Nicotine Delivery Systems (ENDS) conference covering scientific, commercial, and regulatory aspects, from the latest regulations and research to testing methods, standards, product design, potential harm reduction and more.

The ENDS Regulatory Battleground

Dr Nveed Chaudhary, Chief Regulatory Officer at Broughton Nicotine Services will present, ‘The ENDS Regulatory Battleground of Tomorrow' on Wednesday 21st April @3.30pm, addressing the following key topics:

  • ENDS products have revolutionised the ability for smokers to use nicotine in a less harmful way.
  • The focus of reducing the harm to smokers has thus far ignored the harm these products may cause the environment.
  • Regulation is evolving to have a greater focus on the materials used in ENDS products.
  • As an industry our focus should not be only on Tobacco Harm Reduction but on Total Harm reduction - a reduction in harm to smokers and our planet.

The event boasts a packed agenda of high-quality content delivered by expert industry speakers attracting an industry audience from Big Tobacco, ENDS/E-Liquid manufacturers, ingredients manufacturers, regulatory bodies and law firms. The Online Event takes place between 20-21 April 2021. You can view the agenda here.

ENDS Flavours Workshop

Yvonne Wilding, Director of Product Safety and Compliance at Broughton Nicotine Services will attend the ENDS Flavours workshop. The online event will cover trends, behavioural studies, flavour bans, toxicity assessments and product stewardship. The Workshop is held on 14 April 2021.

If you would like to discuss what’s happening in the industry and to find out how Broughton Nicotine Services can help clients in meeting their Regulatory obligations, we would be delighted to speak to you.

 

Schedule a meeting today

 

Can we help you?

Broughton Nicotine Services have deep CRO capabilities and an experienced team of scientific and regulatory professionals to manage full service global regulatory projects. Our knowledge of global regulatory pathways offers significant insights that can be incorporated into your project plans. Our mission is to accelerate safer nicotine-delivery products to market; advancing a smoke-free future.

Book a meeting with us today to discuss your requirements.

 

About the Author

Dr Nveed Chaudhary is Chief Regulatory Officer at Broughton Nicotine Services. He has over 15 years of experience in the Next Generation Nicotine Products (NGPs) industry. His educational background includes a Double Hons Degree in Pharmacology and Physiology from University College London and a PhD in Respiratory Molecular Medicine from the University of Southampton. His goal has always been to reduce the burden that lung disease has on patients, society, and public health. Early in his career he worked for the pharmaceutical industry and at Boehringer Ingelheim was the co-inventor of a novel drug for the treatment of idiopathic pulmonary fibrosis, nintedanib esylate, which received regulatory approval in 2014/15. Since 2006, Nveed had worked at three of the largest tobacco companies in the World, focused on the assessment and subsequent regulatory filing of NGPs, including e-cigarettes, heated tobacco products and modern oral nicotine products. His experience at British American Tobacco and Philip Morris International included leading multi-disciplinary, globally based teams on both pre-clinical and clinical assessment of NGPs. Later in his career at Philip Morris International, Nveed was Director of Strategic Communications, with a focus on Tobacco Harm Reduction (THR). In this role, as well as creating narratives around THR for regulatory and key opinion leader engagement, he also had a critical role in creating the narratives for the Premarket Tobacco Product Applications (PMTA) and Modified Risk Tobacco Product (MRTP) applications for IQOS. Most recently, Nveed directed the PMTA programme at Imperial Brands ensuring the timely submission of PMTA applications to support Imperial Brand’s range of deemed products in the USA. Nveed is a true pioneer for NGPs and has worked collaboratively with FDA in the submission of both PMTAs and MRTPs as well as having heavy involvement in PMTAs for both e-vapor and heated tobacco products. As a scientist and communicator, Nveed is passionate about story-telling and using scientific data to underpin the narratives of both regulatory submissions and tobacco harm reduction.